Good analysis, as always.
You're absolutely right about no credit for isotopes. They own about 65% of the medical subsidiary, valued at $50 million on the European stock exchange -- not a penny of which reflected in the U.S. share price.
Climaco addition clearly shows they've come to recognize and acknowledge their own inability to create shareholder value. "Business as usual" isn't gong to drive the share price. Hopefully, Climaco will earn his keep by coming up with some more innovative ideas.....
Can't say I miss Barney. Board tone is refreshingly optimistic.
None of these "positives" have anything to do with the way the company is run
or its concern for shareholders. From what I can see, you're the only one on this
board that has anything positive to say about management.
Don't care which. But, after 4 years of declining share price, it's time to dump
current management and provide a return for shareholders. Stock has lost 2/3 of its value, investors
have taken gas, while management hopes for good weather to earn 2 cents .....
"Crank that back in and you are where you want to be"?
You mean, earning 2 cents? Where I want to be is with a company that's growing free cash flow by 15--plus percent yearly and a stock price of $30....Either that, or sold for a price of $30. Shareholders have lost four years of a tremendous stock market, with the pile of sh...ii....tt.
That's just the point. They spent "a billion dollars" on all these upgrades, improvements, expansions etc. - AND THEY COULDN'T EVEN EARN 2 cents!!!!!
(The analysts' forecast for Q3). With all that continual CAPEX, this company should't have been weather-dependent for earning 2 cents/ share. By now, with all they've pumped into this company, they should be earning 20 or 30 cents/share.
So, we're to understand, if the weather holds up this quarter, they'll make their 2 cents? Wow, that billion-dollar capex is certainly paying off .........
The $40 million government contract, reported earlier by someone, is an IDIR. It came from a military website. It's basically a sort of blanket umbrella order without any specifics at this point. How much - and when -- gets allocated to PESI is indeterminate at this point. Lot of government contracts issued like this.
Here's another interesting factoid: PESI's medical (isotope) company, as listed on the Polish stock exchange, has a value or $50 million. The way it was formed, PESI owns 64% of this company.
No hype. Just facts.
They were a $60 stock, then a $30, now a $13....You going to blame that
on the weather? Have given shareholders nothing but loss on their investment
for the last 3 years... Is that weather-related.
Been expanding production, when there's
already too much potash production/competition from foreign competitors.... How about buying back shares? Issuing a regular dividend? Giving something to shareholders beside pie-in-the-sky scenarios. I think Icahn could at least get a good price for this company....
PSX had big quarter. Exxon big profit from refining operations etc etc.,
So, why is CLMT not up or riding higher
Time to put this company up for sale, replace management and create some shareholder value.
There's value here, but it's going to take an Icahn type to bring it out.
You'd be silly to sell now. Stock financially stronger and
better positioned than when it was $29. You know, one way or the
other, it's going much higher than that now. CEO holds all the cards
and he's playing for a much higher share price...
They'll pay off debt, for sure, but can and will keep $1 billion or more for other things..
We'll could well get a special dividend and/or stock buyback, particularly if the stock
is under $30 by then....Don't forget, we also have a nicely profitable 3rd quarter to announce
CHK is now positioned to become the "go to" energy company in
its segment. More diversified, faster growing profit potential of any
of his competitors
With the drop in oil prices, analysts will lower estimates of quarterly earnings.
Then, higher nat gas prices and hedged oil will allow chk to handily beat lowered
analyst projections. Company is still making good money, adding to its cash flow and accumulated
cash. All that cost-cutting and hedging will show up big time in Q3 earnings report..